nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—SLC22A2—Vinblastine—testicular cancer	0.164	0.225	CbGbCtD
Metoprolol—SLC22A2—Cisplatin—testicular cancer	0.15	0.206	CbGbCtD
Metoprolol—CYP2C19—Ifosfamide—testicular cancer	0.102	0.14	CbGbCtD
Metoprolol—ABCB1—Dactinomycin—testicular cancer	0.0696	0.0957	CbGbCtD
Metoprolol—ABCB1—Vinblastine—testicular cancer	0.0436	0.0599	CbGbCtD
Metoprolol—CYP2D6—Vinblastine—testicular cancer	0.0411	0.0565	CbGbCtD
Metoprolol—ABCB1—Cisplatin—testicular cancer	0.04	0.055	CbGbCtD
Metoprolol—ABCB1—Etoposide—testicular cancer	0.0393	0.054	CbGbCtD
Metoprolol—ABCB1—Doxorubicin—testicular cancer	0.0268	0.0368	CbGbCtD
Metoprolol—ABCB1—Methotrexate—testicular cancer	0.0259	0.0357	CbGbCtD
Metoprolol—CYP2D6—Doxorubicin—testicular cancer	0.0252	0.0347	CbGbCtD
Metoprolol—Vomiting—Bleomycin—testicular cancer	0.000351	0.00128	CcSEcCtD
Metoprolol—Depression—Methotrexate—testicular cancer	0.000349	0.00128	CcSEcCtD
Metoprolol—Hypotension—Etoposide—testicular cancer	0.000348	0.00127	CcSEcCtD
Metoprolol—Rash—Bleomycin—testicular cancer	0.000348	0.00127	CcSEcCtD
Metoprolol—Pain—Cisplatin—testicular cancer	0.000348	0.00127	CcSEcCtD
Metoprolol—Dermatitis—Bleomycin—testicular cancer	0.000348	0.00127	CcSEcCtD
Metoprolol—Hypersensitivity—Ifosfamide—testicular cancer	0.000347	0.00127	CcSEcCtD
Metoprolol—Conjunctivitis—Methotrexate—testicular cancer	0.00034	0.00125	CcSEcCtD
Metoprolol—Asthenia—Ifosfamide—testicular cancer	0.000338	0.00124	CcSEcCtD
Metoprolol—Sweating—Methotrexate—testicular cancer	0.000335	0.00123	CcSEcCtD
Metoprolol—Photosensitivity reaction—Epirubicin—testicular cancer	0.000335	0.00123	CcSEcCtD
Metoprolol—Feeling abnormal—Cisplatin—testicular cancer	0.000335	0.00123	CcSEcCtD
Metoprolol—Paraesthesia—Etoposide—testicular cancer	0.000334	0.00122	CcSEcCtD
Metoprolol—Weight increased—Epirubicin—testicular cancer	0.000334	0.00122	CcSEcCtD
Metoprolol—Pruritus—Ifosfamide—testicular cancer	0.000334	0.00122	CcSEcCtD
Metoprolol—Dyspnoea—Etoposide—testicular cancer	0.000332	0.00122	CcSEcCtD
Metoprolol—Somnolence—Etoposide—testicular cancer	0.000331	0.00121	CcSEcCtD
Metoprolol—Angina pectoris—Doxorubicin—testicular cancer	0.000331	0.00121	CcSEcCtD
Metoprolol—Hepatobiliary disease—Methotrexate—testicular cancer	0.000331	0.00121	CcSEcCtD
Metoprolol—Pneumonia—Epirubicin—testicular cancer	0.000329	0.00121	CcSEcCtD
Metoprolol—Nausea—Bleomycin—testicular cancer	0.000328	0.0012	CcSEcCtD
Metoprolol—Vomiting—Dactinomycin—testicular cancer	0.000327	0.0012	CcSEcCtD
Metoprolol—Agranulocytosis—Methotrexate—testicular cancer	0.000326	0.0012	CcSEcCtD
Metoprolol—Rash—Dactinomycin—testicular cancer	0.000324	0.00119	CcSEcCtD
Metoprolol—Diarrhoea—Ifosfamide—testicular cancer	0.000323	0.00118	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Etoposide—testicular cancer	0.000322	0.00118	CcSEcCtD
Metoprolol—Body temperature increased—Cisplatin—testicular cancer	0.000321	0.00118	CcSEcCtD
Metoprolol—Fatigue—Etoposide—testicular cancer	0.000321	0.00118	CcSEcCtD
Metoprolol—Jaundice—Epirubicin—testicular cancer	0.000319	0.00117	CcSEcCtD
Metoprolol—Pain—Etoposide—testicular cancer	0.000318	0.00117	CcSEcCtD
Metoprolol—Constipation—Etoposide—testicular cancer	0.000318	0.00117	CcSEcCtD
Metoprolol—Conjunctivitis—Epirubicin—testicular cancer	0.000318	0.00117	CcSEcCtD
Metoprolol—Hepatitis—Methotrexate—testicular cancer	0.000314	0.00115	CcSEcCtD
Metoprolol—Sweating—Epirubicin—testicular cancer	0.000314	0.00115	CcSEcCtD
Metoprolol—Dizziness—Ifosfamide—testicular cancer	0.000312	0.00114	CcSEcCtD
Metoprolol—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00031	0.00114	CcSEcCtD
Metoprolol—Hepatobiliary disease—Epirubicin—testicular cancer	0.00031	0.00113	CcSEcCtD
Metoprolol—Weight increased—Doxorubicin—testicular cancer	0.000309	0.00113	CcSEcCtD
Metoprolol—Feeling abnormal—Etoposide—testicular cancer	0.000307	0.00112	CcSEcCtD
Metoprolol—Nausea—Dactinomycin—testicular cancer	0.000306	0.00112	CcSEcCtD
Metoprolol—Agranulocytosis—Epirubicin—testicular cancer	0.000305	0.00112	CcSEcCtD
Metoprolol—Pneumonia—Doxorubicin—testicular cancer	0.000305	0.00112	CcSEcCtD
Metoprolol—Gastrointestinal pain—Etoposide—testicular cancer	0.000305	0.00112	CcSEcCtD
Metoprolol—Visual impairment—Methotrexate—testicular cancer	0.000303	0.00111	CcSEcCtD
Metoprolol—Vomiting—Ifosfamide—testicular cancer	0.0003	0.0011	CcSEcCtD
Metoprolol—Hypersensitivity—Cisplatin—testicular cancer	0.0003	0.0011	CcSEcCtD
Metoprolol—Bradycardia—Epirubicin—testicular cancer	0.000299	0.0011	CcSEcCtD
Metoprolol—Rash—Ifosfamide—testicular cancer	0.000297	0.00109	CcSEcCtD
Metoprolol—Dermatitis—Ifosfamide—testicular cancer	0.000297	0.00109	CcSEcCtD
Metoprolol—Urticaria—Etoposide—testicular cancer	0.000296	0.00108	CcSEcCtD
Metoprolol—Jaundice—Doxorubicin—testicular cancer	0.000295	0.00108	CcSEcCtD
Metoprolol—Rhinitis—Epirubicin—testicular cancer	0.000295	0.00108	CcSEcCtD
Metoprolol—Abdominal pain—Etoposide—testicular cancer	0.000294	0.00108	CcSEcCtD
Metoprolol—Body temperature increased—Etoposide—testicular cancer	0.000294	0.00108	CcSEcCtD
Metoprolol—Conjunctivitis—Doxorubicin—testicular cancer	0.000294	0.00108	CcSEcCtD
Metoprolol—Hepatitis—Epirubicin—testicular cancer	0.000294	0.00108	CcSEcCtD
Metoprolol—Eye disorder—Methotrexate—testicular cancer	0.000293	0.00107	CcSEcCtD
Metoprolol—Tinnitus—Methotrexate—testicular cancer	0.000293	0.00107	CcSEcCtD
Metoprolol—Asthenia—Cisplatin—testicular cancer	0.000292	0.00107	CcSEcCtD
Metoprolol—Cardiac disorder—Methotrexate—testicular cancer	0.000291	0.00107	CcSEcCtD
Metoprolol—Sweating—Doxorubicin—testicular cancer	0.00029	0.00106	CcSEcCtD
Metoprolol—Oedema peripheral—Epirubicin—testicular cancer	0.000289	0.00106	CcSEcCtD
Metoprolol—Connective tissue disorder—Epirubicin—testicular cancer	0.000289	0.00106	CcSEcCtD
Metoprolol—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000286	0.00105	CcSEcCtD
Metoprolol—Angiopathy—Methotrexate—testicular cancer	0.000285	0.00104	CcSEcCtD
Metoprolol—Immune system disorder—Methotrexate—testicular cancer	0.000284	0.00104	CcSEcCtD
Metoprolol—Visual impairment—Epirubicin—testicular cancer	0.000283	0.00104	CcSEcCtD
Metoprolol—Mediastinal disorder—Methotrexate—testicular cancer	0.000283	0.00104	CcSEcCtD
Metoprolol—Agranulocytosis—Doxorubicin—testicular cancer	0.000283	0.00104	CcSEcCtD
Metoprolol—Nausea—Ifosfamide—testicular cancer	0.00028	0.00103	CcSEcCtD
Metoprolol—Diarrhoea—Cisplatin—testicular cancer	0.000278	0.00102	CcSEcCtD
Metoprolol—Alopecia—Methotrexate—testicular cancer	0.000277	0.00102	CcSEcCtD
Metoprolol—Bradycardia—Doxorubicin—testicular cancer	0.000277	0.00101	CcSEcCtD
Metoprolol—Mental disorder—Methotrexate—testicular cancer	0.000275	0.00101	CcSEcCtD
Metoprolol—Eye disorder—Epirubicin—testicular cancer	0.000275	0.00101	CcSEcCtD
Metoprolol—Hypersensitivity—Etoposide—testicular cancer	0.000274	0.001	CcSEcCtD
Metoprolol—Tinnitus—Epirubicin—testicular cancer	0.000274	0.001	CcSEcCtD
Metoprolol—Cardiac disorder—Epirubicin—testicular cancer	0.000273	0.000999	CcSEcCtD
Metoprolol—Rhinitis—Doxorubicin—testicular cancer	0.000273	0.000998	CcSEcCtD
Metoprolol—Hepatitis—Doxorubicin—testicular cancer	0.000272	0.000996	CcSEcCtD
Metoprolol—Oedema peripheral—Doxorubicin—testicular cancer	0.000268	0.000981	CcSEcCtD
Metoprolol—Dysgeusia—Methotrexate—testicular cancer	0.000268	0.00098	CcSEcCtD
Metoprolol—Asthenia—Etoposide—testicular cancer	0.000267	0.000979	CcSEcCtD
Metoprolol—Connective tissue disorder—Doxorubicin—testicular cancer	0.000267	0.000978	CcSEcCtD
Metoprolol—Angiopathy—Epirubicin—testicular cancer	0.000267	0.000976	CcSEcCtD
Metoprolol—Immune system disorder—Epirubicin—testicular cancer	0.000265	0.000972	CcSEcCtD
Metoprolol—Mediastinal disorder—Epirubicin—testicular cancer	0.000265	0.00097	CcSEcCtD
Metoprolol—Pruritus—Etoposide—testicular cancer	0.000263	0.000965	CcSEcCtD
Metoprolol—Arrhythmia—Epirubicin—testicular cancer	0.000262	0.000961	CcSEcCtD
Metoprolol—Visual impairment—Doxorubicin—testicular cancer	0.000262	0.00096	CcSEcCtD
Metoprolol—Alopecia—Epirubicin—testicular cancer	0.00026	0.000951	CcSEcCtD
Metoprolol—Vomiting—Cisplatin—testicular cancer	0.000258	0.000947	CcSEcCtD
Metoprolol—Vision blurred—Methotrexate—testicular cancer	0.000258	0.000943	CcSEcCtD
Metoprolol—Mental disorder—Epirubicin—testicular cancer	0.000257	0.000943	CcSEcCtD
Metoprolol—Rash—Cisplatin—testicular cancer	0.000256	0.000939	CcSEcCtD
Metoprolol—Dermatitis—Cisplatin—testicular cancer	0.000256	0.000938	CcSEcCtD
Metoprolol—Diarrhoea—Etoposide—testicular cancer	0.000255	0.000933	CcSEcCtD
Metoprolol—Eye disorder—Doxorubicin—testicular cancer	0.000254	0.000931	CcSEcCtD
Metoprolol—Tinnitus—Doxorubicin—testicular cancer	0.000253	0.000928	CcSEcCtD
Metoprolol—Cardiac disorder—Doxorubicin—testicular cancer	0.000252	0.000924	CcSEcCtD
Metoprolol—Flatulence—Epirubicin—testicular cancer	0.000252	0.000923	CcSEcCtD
Metoprolol—Tension—Epirubicin—testicular cancer	0.000251	0.000919	CcSEcCtD
Metoprolol—Dysgeusia—Epirubicin—testicular cancer	0.00025	0.000917	CcSEcCtD
Metoprolol—Nervousness—Epirubicin—testicular cancer	0.000248	0.00091	CcSEcCtD
Metoprolol—Angiopathy—Doxorubicin—testicular cancer	0.000247	0.000903	CcSEcCtD
Metoprolol—Dizziness—Etoposide—testicular cancer	0.000246	0.000902	CcSEcCtD
Metoprolol—Muscle spasms—Epirubicin—testicular cancer	0.000246	0.000901	CcSEcCtD
Metoprolol—Immune system disorder—Doxorubicin—testicular cancer	0.000246	0.000899	CcSEcCtD
Metoprolol—Vertigo—Methotrexate—testicular cancer	0.000246	0.000899	CcSEcCtD
Metoprolol—Mediastinal disorder—Doxorubicin—testicular cancer	0.000245	0.000897	CcSEcCtD
Metoprolol—Leukopenia—Methotrexate—testicular cancer	0.000245	0.000896	CcSEcCtD
Metoprolol—Arrhythmia—Doxorubicin—testicular cancer	0.000243	0.000889	CcSEcCtD
Metoprolol—Nausea—Cisplatin—testicular cancer	0.000241	0.000884	CcSEcCtD
Metoprolol—Vision blurred—Epirubicin—testicular cancer	0.000241	0.000883	CcSEcCtD
Metoprolol—Alopecia—Doxorubicin—testicular cancer	0.00024	0.00088	CcSEcCtD
Metoprolol—Mental disorder—Doxorubicin—testicular cancer	0.000238	0.000872	CcSEcCtD
Metoprolol—Vomiting—Etoposide—testicular cancer	0.000237	0.000867	CcSEcCtD
Metoprolol—Rash—Etoposide—testicular cancer	0.000235	0.00086	CcSEcCtD
Metoprolol—Dermatitis—Etoposide—testicular cancer	0.000235	0.000859	CcSEcCtD
Metoprolol—Headache—Etoposide—testicular cancer	0.000233	0.000854	CcSEcCtD
Metoprolol—Flatulence—Doxorubicin—testicular cancer	0.000233	0.000854	CcSEcCtD
Metoprolol—Arthralgia—Methotrexate—testicular cancer	0.000233	0.000852	CcSEcCtD
Metoprolol—Chest pain—Methotrexate—testicular cancer	0.000233	0.000852	CcSEcCtD
Metoprolol—Tension—Doxorubicin—testicular cancer	0.000232	0.000851	CcSEcCtD
Metoprolol—Dysgeusia—Doxorubicin—testicular cancer	0.000232	0.000849	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000231	0.000846	CcSEcCtD
Metoprolol—Nervousness—Doxorubicin—testicular cancer	0.00023	0.000842	CcSEcCtD
Metoprolol—Vertigo—Epirubicin—testicular cancer	0.00023	0.000842	CcSEcCtD
Metoprolol—Syncope—Epirubicin—testicular cancer	0.000229	0.00084	CcSEcCtD
Metoprolol—Leukopenia—Epirubicin—testicular cancer	0.000229	0.000839	CcSEcCtD
Metoprolol—Muscle spasms—Doxorubicin—testicular cancer	0.000228	0.000833	CcSEcCtD
Metoprolol—Palpitations—Epirubicin—testicular cancer	0.000226	0.000828	CcSEcCtD
Metoprolol—Confusional state—Methotrexate—testicular cancer	0.000225	0.000824	CcSEcCtD
Metoprolol—Loss of consciousness—Epirubicin—testicular cancer	0.000225	0.000823	CcSEcCtD
Metoprolol—Vision blurred—Doxorubicin—testicular cancer	0.000223	0.000817	CcSEcCtD
Metoprolol—Nausea—Etoposide—testicular cancer	0.000221	0.00081	CcSEcCtD
Metoprolol—Hypertension—Epirubicin—testicular cancer	0.000221	0.000809	CcSEcCtD
Metoprolol—Nervous system disorder—Methotrexate—testicular cancer	0.000219	0.000801	CcSEcCtD
Metoprolol—Thrombocytopenia—Methotrexate—testicular cancer	0.000218	0.0008	CcSEcCtD
Metoprolol—Chest pain—Epirubicin—testicular cancer	0.000218	0.000798	CcSEcCtD
Metoprolol—Arthralgia—Epirubicin—testicular cancer	0.000218	0.000798	CcSEcCtD
Metoprolol—Anxiety—Epirubicin—testicular cancer	0.000217	0.000795	CcSEcCtD
Metoprolol—Skin disorder—Methotrexate—testicular cancer	0.000217	0.000794	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000216	0.000792	CcSEcCtD
Metoprolol—Hyperhidrosis—Methotrexate—testicular cancer	0.000216	0.00079	CcSEcCtD
Metoprolol—Dry mouth—Epirubicin—testicular cancer	0.000213	0.00078	CcSEcCtD
Metoprolol—Vertigo—Doxorubicin—testicular cancer	0.000213	0.000779	CcSEcCtD
Metoprolol—Syncope—Doxorubicin—testicular cancer	0.000212	0.000777	CcSEcCtD
Metoprolol—Leukopenia—Doxorubicin—testicular cancer	0.000212	0.000776	CcSEcCtD
Metoprolol—Confusional state—Epirubicin—testicular cancer	0.00021	0.000771	CcSEcCtD
Metoprolol—Palpitations—Doxorubicin—testicular cancer	0.000209	0.000766	CcSEcCtD
Metoprolol—Oedema—Epirubicin—testicular cancer	0.000209	0.000765	CcSEcCtD
Metoprolol—Hypotension—Methotrexate—testicular cancer	0.000208	0.000763	CcSEcCtD
Metoprolol—Loss of consciousness—Doxorubicin—testicular cancer	0.000208	0.000762	CcSEcCtD
Metoprolol—Shock—Epirubicin—testicular cancer	0.000205	0.000752	CcSEcCtD
Metoprolol—Nervous system disorder—Epirubicin—testicular cancer	0.000205	0.00075	CcSEcCtD
Metoprolol—Thrombocytopenia—Epirubicin—testicular cancer	0.000204	0.000749	CcSEcCtD
Metoprolol—Hypertension—Doxorubicin—testicular cancer	0.000204	0.000748	CcSEcCtD
Metoprolol—Tachycardia—Epirubicin—testicular cancer	0.000204	0.000746	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000203	0.000744	CcSEcCtD
Metoprolol—Skin disorder—Epirubicin—testicular cancer	0.000203	0.000743	CcSEcCtD
Metoprolol—Hyperhidrosis—Epirubicin—testicular cancer	0.000202	0.000739	CcSEcCtD
Metoprolol—Insomnia—Methotrexate—testicular cancer	0.000202	0.000739	CcSEcCtD
Metoprolol—Chest pain—Doxorubicin—testicular cancer	0.000201	0.000738	CcSEcCtD
Metoprolol—Arthralgia—Doxorubicin—testicular cancer	0.000201	0.000738	CcSEcCtD
Metoprolol—Anxiety—Doxorubicin—testicular cancer	0.000201	0.000735	CcSEcCtD
Metoprolol—Paraesthesia—Methotrexate—testicular cancer	0.0002	0.000734	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.0002	0.000733	CcSEcCtD
Metoprolol—Dyspnoea—Methotrexate—testicular cancer	0.000199	0.000728	CcSEcCtD
Metoprolol—Somnolence—Methotrexate—testicular cancer	0.000198	0.000726	CcSEcCtD
Metoprolol—Dry mouth—Doxorubicin—testicular cancer	0.000197	0.000722	CcSEcCtD
Metoprolol—Dyspepsia—Methotrexate—testicular cancer	0.000196	0.000719	CcSEcCtD
Metoprolol—Hypotension—Epirubicin—testicular cancer	0.000195	0.000714	CcSEcCtD
Metoprolol—Confusional state—Doxorubicin—testicular cancer	0.000195	0.000713	CcSEcCtD
Metoprolol—Oedema—Doxorubicin—testicular cancer	0.000193	0.000707	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000193	0.000705	CcSEcCtD
Metoprolol—Fatigue—Methotrexate—testicular cancer	0.000192	0.000704	CcSEcCtD
Metoprolol—Pain—Methotrexate—testicular cancer	0.000191	0.000699	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.00019	0.000697	CcSEcCtD
Metoprolol—Shock—Doxorubicin—testicular cancer	0.00019	0.000696	CcSEcCtD
Metoprolol—Nervous system disorder—Doxorubicin—testicular cancer	0.000189	0.000694	CcSEcCtD
Metoprolol—Thrombocytopenia—Doxorubicin—testicular cancer	0.000189	0.000693	CcSEcCtD
Metoprolol—Insomnia—Epirubicin—testicular cancer	0.000189	0.000691	CcSEcCtD
Metoprolol—Tachycardia—Doxorubicin—testicular cancer	0.000189	0.00069	CcSEcCtD
Metoprolol—Skin disorder—Doxorubicin—testicular cancer	0.000188	0.000687	CcSEcCtD
Metoprolol—Paraesthesia—Epirubicin—testicular cancer	0.000187	0.000687	CcSEcCtD
Metoprolol—Hyperhidrosis—Doxorubicin—testicular cancer	0.000187	0.000684	CcSEcCtD
Metoprolol—Dyspnoea—Epirubicin—testicular cancer	0.000186	0.000682	CcSEcCtD
Metoprolol—Somnolence—Epirubicin—testicular cancer	0.000186	0.00068	CcSEcCtD
Metoprolol—Feeling abnormal—Methotrexate—testicular cancer	0.000184	0.000673	CcSEcCtD
Metoprolol—Dyspepsia—Epirubicin—testicular cancer	0.000184	0.000673	CcSEcCtD
Metoprolol—Gastrointestinal pain—Methotrexate—testicular cancer	0.000182	0.000668	CcSEcCtD
Metoprolol—Hypotension—Doxorubicin—testicular cancer	0.00018	0.000661	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00018	0.00066	CcSEcCtD
Metoprolol—Fatigue—Epirubicin—testicular cancer	0.00018	0.000659	CcSEcCtD
Metoprolol—Pain—Epirubicin—testicular cancer	0.000179	0.000654	CcSEcCtD
Metoprolol—Constipation—Epirubicin—testicular cancer	0.000179	0.000654	CcSEcCtD
Metoprolol—Urticaria—Methotrexate—testicular cancer	0.000177	0.000649	CcSEcCtD
Metoprolol—Body temperature increased—Methotrexate—testicular cancer	0.000176	0.000646	CcSEcCtD
Metoprolol—Abdominal pain—Methotrexate—testicular cancer	0.000176	0.000646	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000176	0.000644	CcSEcCtD
Metoprolol—Insomnia—Doxorubicin—testicular cancer	0.000175	0.00064	CcSEcCtD
Metoprolol—Paraesthesia—Doxorubicin—testicular cancer	0.000173	0.000635	CcSEcCtD
Metoprolol—Dyspnoea—Doxorubicin—testicular cancer	0.000172	0.000631	CcSEcCtD
Metoprolol—Feeling abnormal—Epirubicin—testicular cancer	0.000172	0.00063	CcSEcCtD
Metoprolol—Somnolence—Doxorubicin—testicular cancer	0.000172	0.000629	CcSEcCtD
Metoprolol—Gastrointestinal pain—Epirubicin—testicular cancer	0.000171	0.000625	CcSEcCtD
Metoprolol—Dyspepsia—Doxorubicin—testicular cancer	0.00017	0.000623	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000167	0.000611	CcSEcCtD
Metoprolol—Fatigue—Doxorubicin—testicular cancer	0.000167	0.00061	CcSEcCtD
Metoprolol—Urticaria—Epirubicin—testicular cancer	0.000166	0.000607	CcSEcCtD
Metoprolol—Constipation—Doxorubicin—testicular cancer	0.000165	0.000605	CcSEcCtD
Metoprolol—Pain—Doxorubicin—testicular cancer	0.000165	0.000605	CcSEcCtD
Metoprolol—Body temperature increased—Epirubicin—testicular cancer	0.000165	0.000604	CcSEcCtD
Metoprolol—Abdominal pain—Epirubicin—testicular cancer	0.000165	0.000604	CcSEcCtD
Metoprolol—Hypersensitivity—Methotrexate—testicular cancer	0.000164	0.000602	CcSEcCtD
Metoprolol—Asthenia—Methotrexate—testicular cancer	0.00016	0.000586	CcSEcCtD
Metoprolol—Feeling abnormal—Doxorubicin—testicular cancer	0.000159	0.000583	CcSEcCtD
Metoprolol—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000158	0.000578	CcSEcCtD
Metoprolol—Pruritus—Methotrexate—testicular cancer	0.000158	0.000578	CcSEcCtD
Metoprolol—Hypersensitivity—Epirubicin—testicular cancer	0.000154	0.000563	CcSEcCtD
Metoprolol—Urticaria—Doxorubicin—testicular cancer	0.000153	0.000562	CcSEcCtD
Metoprolol—Abdominal pain—Doxorubicin—testicular cancer	0.000153	0.000559	CcSEcCtD
Metoprolol—Body temperature increased—Doxorubicin—testicular cancer	0.000153	0.000559	CcSEcCtD
Metoprolol—Diarrhoea—Methotrexate—testicular cancer	0.000153	0.000559	CcSEcCtD
Metoprolol—Asthenia—Epirubicin—testicular cancer	0.00015	0.000549	CcSEcCtD
Metoprolol—Pruritus—Epirubicin—testicular cancer	0.000148	0.000541	CcSEcCtD
Metoprolol—Dizziness—Methotrexate—testicular cancer	0.000148	0.00054	CcSEcCtD
Metoprolol—Diarrhoea—Epirubicin—testicular cancer	0.000143	0.000523	CcSEcCtD
Metoprolol—Hypersensitivity—Doxorubicin—testicular cancer	0.000142	0.000521	CcSEcCtD
Metoprolol—Vomiting—Methotrexate—testicular cancer	0.000142	0.000519	CcSEcCtD
Metoprolol—Rash—Methotrexate—testicular cancer	0.000141	0.000515	CcSEcCtD
Metoprolol—Dermatitis—Methotrexate—testicular cancer	0.000141	0.000515	CcSEcCtD
Metoprolol—Headache—Methotrexate—testicular cancer	0.00014	0.000512	CcSEcCtD
Metoprolol—Asthenia—Doxorubicin—testicular cancer	0.000139	0.000508	CcSEcCtD
Metoprolol—Dizziness—Epirubicin—testicular cancer	0.000138	0.000506	CcSEcCtD
Metoprolol—Pruritus—Doxorubicin—testicular cancer	0.000137	0.0005	CcSEcCtD
Metoprolol—Vomiting—Epirubicin—testicular cancer	0.000133	0.000486	CcSEcCtD
Metoprolol—Nausea—Methotrexate—testicular cancer	0.000133	0.000485	CcSEcCtD
Metoprolol—Diarrhoea—Doxorubicin—testicular cancer	0.000132	0.000484	CcSEcCtD
Metoprolol—Rash—Epirubicin—testicular cancer	0.000132	0.000482	CcSEcCtD
Metoprolol—Dermatitis—Epirubicin—testicular cancer	0.000132	0.000482	CcSEcCtD
Metoprolol—Headache—Epirubicin—testicular cancer	0.000131	0.000479	CcSEcCtD
Metoprolol—Dizziness—Doxorubicin—testicular cancer	0.000128	0.000468	CcSEcCtD
Metoprolol—Nausea—Epirubicin—testicular cancer	0.000124	0.000454	CcSEcCtD
Metoprolol—Vomiting—Doxorubicin—testicular cancer	0.000123	0.00045	CcSEcCtD
Metoprolol—Rash—Doxorubicin—testicular cancer	0.000122	0.000446	CcSEcCtD
Metoprolol—Dermatitis—Doxorubicin—testicular cancer	0.000122	0.000446	CcSEcCtD
Metoprolol—Headache—Doxorubicin—testicular cancer	0.000121	0.000443	CcSEcCtD
Metoprolol—Nausea—Doxorubicin—testicular cancer	0.000115	0.00042	CcSEcCtD
